Russell Kern - 09 Jun 2021 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
EVP and CSO, Director, 10%+ Owner
Signature
/s/ Sophia Garnette, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 14:36:45 UTC
Next filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 09 Jun 2021 Common Stock 250,000 $0.3900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3/36th of the shares underlying such options shall vest on 09/09/2021, and the remaining share in equal monthly installments over a period of 33 months.